Cacao Bean Polyphenols Inhibit Cardiac Hypertrophy and Systolic Dysfunction in Pressure Overload-induced Heart Failure Model Mice

Abstract

Pathological stresses such as pressure overload and myocardial infarction induce cardiac hypertrophy, which increases the risk of heart failure. Cacao bean polyphenols have recently gained considerable attention for their beneficial effects on cardiovascular diseases. This study investigated the effect of cacao bean polyphenols on the development of cardiac hypertrophy and heart failure. Cardiomyocytes from neonatal rats were pre-treated with cacao bean polyphenols and then stimulated with 30 µM phenylephrine. C57BL/6j male mice were subjected to sham or transverse aortic constriction surgery and then orally administered with vehicle or cacao bean polyphenols. Cardiac hypertrophy and function were examined by echocardiography. In cardiomyocytes, cacao bean polyphenols significantly suppressed phenylephrine-induced cardiomyocyte hypertrophy and hypertrophic gene transcription. Extracellular signal-regulated kinase 1/2 and GATA binding protein 4 phosphorylation induced by phenylephrine was inhibited by cacao bean polyphenols treatment in the cardiomyocytes. Cacao bean polyphenols treatment at 1200 mg/kg significantly ameliorated left ventricular posterior wall thickness, fractional shortening, hypertrophic gene transcription, cardiac hypertrophy, cardiac fibrosis, and extracellular signal-regulated kinase 1/2 phosphorylation induced by pressure overload. In conclusion, these findings suggest that cacao bean polyphenols prevent pressure overload-induced cardiac hypertrophy and systolic dysfunction by inhibiting the extracellular signal-regulated kinase 1/2-GATA binding protein 4 pathway in cardiomyocytes. Thus, cacao bean polyphenols may be useful for heart failure therapy in humans.

Key words

cacao bean polyphenols - cardiac hypertrophy - heart failure - ERK1/2

Publication History

Received: 06 January 2020

Accepted after revision: 31 May 2020

Article published online:
09 July 2020

• References

• 1 Braunwald E. The war against heart failure: The Lancet lecture. Lancet 2015; 385: 812-824
• 2 Roger VL. Heart failure. Int Encycl Public Heal 2016; 1: 520-526
• 3 Schiattarella GG, Hill JA. Is inhibition of hypertrophy a good therapeutic strategy in ventricular pressure overload?. Circulation 2015; 131: 1435-1447
• 4 van Berlo JH, Maillet M, Molkentin JD. Review series signaling effectors underlying pathologic growth and remodeling of the heart. Conflict 2013; 123: 37-45
• 5 Mutlak M, Kehat I. Extracellular signal-regulated kinases 1/2 as regulators of cardiac hypertrophy. Front Pharmacol 2015; 6: 1-8
• 6 Katanasaka Y, Suzuki H, Sunagawa Y, Hasegawa K, Morimoto T. Regulation of cardiac transcription factor GATA4 by post-translational modification in cardiomyocyte hypertrophy and heart failure. Int Heart J 2016; 57: 672-675
• 7 Katanasaka Y, Sunagawa Y, Hasegawa K, Morimoto T. Application of curcumin to heart failure therapy by targeting transcriptional pathway in cardiomyocytes. Biol Pharm Bull 2013; 36: 13-17
• 8 Suzuki H, Katanasaka Y, Sunagawa Y, Miyazaki Y, Funamoto M, Wada H, Hasegawa K, Morimoto T. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p 300 and GATA4. Biochim Biophys Acta – Mol Basis Dis 2016; 1862: 1544-1557
• 9 Morimoto T, Hasegawa K, Kaburagi S, Kakita T, Wada H, Yanazume T, Sasayama S. Phosphorylation of GATA-4 is involved in α1-adrenergic agonist- responsive transcription of the endothelin-1 gene in cardiac myocytes. J Biol Chem 2000; 275: 13721-13726
• 10 Hirai M, Ono K, Morimoto T, Kawamura T, Wada H, Kita T, Hasegawa K. FOG-2 competes with GATA-4 for transcriptional coactivator p300 and represses hypertrophic responses in cardiac myocytes. J Biol Chem 2004; 279: 37640-37650
• 11 Sunagawa Y, Morimoto T, Takaya T, Kaichi S, Wada H, Kawamura T, Fujita M, Shimatsu A, Kita T, Hasegawa K. Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes. J Biol Chem 2010; 285: 9556-9568
• 12 Takaya T, Kawamura T, Morimoto T, Ono K, Kita T, Shimatsu A, Hasegawa K. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes. J Biol Chem 2008; 283: 9828-9835
• 13 Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, Nagasawa A, Komeda M, Fujita M, Shimatsu A, Kita T, Hasegawa K. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 2008; 118: 868-878
• 14 Sunagawa Y, Morimoto T, Wada H, Takaya T, Katanasaka Y, Kawamura T, Yanagi S, Marui A, Sakata R, Shimatsu A, Kimura T, Kakeya H, Fujita M, Hasegawa K. A natural p300-specific histone acetyltransferase inhibitor, curcumin, in addition to angiotensin-converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats. Circ J 2011; 75: 2151-2159
• 15 Wickramasuriya AM, Dunwell JM. Cacao biotechnology: current status and future prospects. Plant Biotechnol J 2018; 16: 4-17
• 16 Khan N, Khymenets O, Urpí-Sardà M, Tulipani S, Garcia-Aloy M, Monagas M, Mora-Cubillos X, Llorach R, Andres-Lacueva C. Cocoa polyphenols and inflammatory markers of cardiovascular disease. Nutrients 2014; 6: 844-880
• 17 Huang CC, Tung YT, Huang WC, Chen YM, Hsu YJ, Hsu MC. Beneficial effects of cocoa, coffee, green tea, and garcinia complex supplement on diet induced obesity in rats. BMC Complement Altern Med 2016; 16: 1-10
• 18 Mccullough ML, Chevaux K, Jackson L, Preston M, Martinez G, Schmitz HH, Coletti C, Campos H, Hollenberg NK. Hypertension, the Kuna, and the epidemiology of flavanols. J Cardiovasc Pharmacol 2006; 47: S103-S121
• 19 Hollenberg NK, Fisher ND, McCullough ML. Flavanols, the Kuna, cocoa consumption, and nitric oxide. J Am Soc Hypertens 2009; 3: 105-112
• 20 Gong F, Yao S, Wan J, Gan X. Chocolate consumption and risk of heart failure: a meta-Analysis of prospective studies. Nutrients 2017; 9: 402
• 21 Quiñones M, Miguel M, Aleixandre A. Beneficial effects of polyphenols on cardiovascular disease. Pharmacol Res 2013; 68: 125-131
• 22 Sunagawa Y, Sono S, Katanasaka Y, Funamoto M, Hirano S, Miyazaki Y, Hojo Y, Suzuki H, Morimoto E, Marui A, Sakata R, Ueno M, Kakeya H, Wada H, Hasegawa K, Morimoto T. Optimal dose-setting study of curcumin for improvement of left ventricular systolic function after myocardial infarction in rats. J Pharmacol Sci 2014; 126: 329-336
• 23 Aprotosoaie A, Miron A, Trifan A, Luca V, Costache II. The cardiovascular effects of cocoa polyphenols–an overview. Diseases 2016; 4: 39
• 24 Rimbach G, Melchin M, Moehring J, Wagner AE. Polyphenols from cocoa and vascular health–a critical review. Int J Mol Sci 2009; 10: 4290-4309
• 25 Zempo H, Suzuki JI, Watanabe R, Wakayama K, Kumagai H, Ikeda Y, Akazawa H, Komuro I, Isobe M. Cacao polyphenols ameliorate autoimmune myocarditis in mice. Hypertens Res 2016; 39: 203-209
• 26 Flammer AJ, Sudano I, Wolfrum M, Thomas R, Enseleit F, Périat D, Kaiser P, Hirt A, Hermann M, Serafini M, Lévêques A, Lüscher TF, Ruschitzka F, Noll G, Corti R. Cardiovascular effects of flavanol-rich chocolate in patients with heart failure. Eur Heart J 2012; 33: 2172-2180
• 27 Desch S, Schmidt J, Kobler D, Sonnabend M, Eitel I, Sareban M, Rahimi K, Schuler G, Thiele H. Effect of cocoa products on blood pressure: Systematic review and meta-analysis. Am J Hypertens 2010; 23: 97-103
• 28 Yasuda A, Natsume M, Sasaki K, Baba S, Nakamura Y, Kanegae M, Nagaoka S. Cacao procyanidins reduce plasma cholesterol and increase fecal steroid excretion in rats fed a high-cholesterol diet. Biofactors 2008; 33: 211-223
• 29 Fraga CG, Oteiza PI. Dietary flavonoids: Role of (−)-epicatechin and related procyanidins in cell signaling. Free Radic Biol Med 2011; 51: 813-823
• 30 Yahfoufi N, Alsadi N, Jambi M, Matar C. The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients 2018; 10: 1-23
• 31 Nam JK, Ki WL, Dong EL, Rogozin EA, Bode AM, Hyong JL, Dong Z. Cocoa procyanidins suppress transformation by inhibiting mitogen-activated protein kinase kinase. J Biol Chem 2008; 283: 20664-20673
• 32 Zhang WY, Liu HQ, Xie KQ, Yin LL, Li Y, Kwik-Uribe CL, Zhu XZ. Procyanidin dimer B2 [epicatechin-(4β-8)-epicatechin] suppresses the expression of cyclooxygenase-2 in endotoxin-treated monocytic cells. Biochem Biophys Res Commun 2006; 345: 508-515
• 33 Yamazaki T, Komuro I, Yazaki Y. Signalling pathways for cardiac hypertrophy. Cell Signal 1998; 10: 693-698
• 34 Bueno OF, Molkentin JD. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 2002; 91: 776-781
• 35 Wu QQ, Ni J, Zhang N, Liao HH, Tang QZ, Deng W. Andrographolide protects against aortic banding-induced experimental cardiac hypertrophy by inhibiting MAPKs Signaling. Front Pharmacol 2017; 8: 1-17
• 36 Yanazume T, Hasegawa K, Wada H, Morimoto T, Abe M, Kawamura T, Sasayama S. Rho/ROCK pathway contributes to the activation of extracellular signal-regulated kinase/GATA-4 during myocardial cell hypertrophy. J Biol Chem 2002; 277: 8618-8625
• 37 Van Berlo JH, Elrod JW, Aronow BJ, Pu WT, Molkentin JD. Serine 105 phosphorylation of transcription factor GATA4 is necessary for stress-induced cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A 2011; 108: 12331-12336
• 38 Yanazume T, Hasegawa K, Morimoto T, Kawamura T, Wada H, Matsumori A, Kawase Y, Hirai M, Kita T. Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol Cell Biol 2003; 23: 3593-3606
• 39 Goya L, Martín MÁ, Sarriá B, Ramos S, Mateos R, Bravo L. et al. Effect of cocoa and its flavonoids on biomarkers of inflammation: studies of cell culture, animals and humans. Nutrients 2016; 8: 212
• 40 Natsume M, Osakabe N, Yamagushi M, Takizawa T, Nakamura T, Miyatake H, Hatano T, Yoshida T. Analyses of polyphenols in cacao liquor, cocoa, and chocolate by normal by normal-phase and reversed-phase HPLC. Biosci Biotechnol Biochem 2000; 64: 2581-2587
• 41 deAlmeida AC, van Oort RJ, Wehrens XHT. Transverse aortic constriction in mice. J Vis Exp 2010; 38: 7-9
• 42 Tarnavski O, McMullen JR, Schinke M, Nie Q, Kong S, Izumo S. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics 2004; 16: 349-360
• 43 Ruan G, Ren H, Zhang C, Zhu X, Xu C, Wang L. Cardioprotective effects of QiShenYiQi dripping pills on transverse aortic constriction-induced heart failure in mice. Front Physiol 2018; 9: 324